RPRX

Latest SEC Filings & News for RPRX

1 most recent filing and news item mentioning RPRX. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/RPRX/news?limit=20"

Pull RPRX filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

Earnings|Guidance|M&A|OfferingAug 5, 2026Positive

Royalty Pharma Rises Portfolio Receipts Guidance to $3.4-$3.5B

The company reported strong Q2 2026 results and raised its full-year Portfolio Receipts guidance range. Additionally, it announced capital deployment of $1.1 billion and pipeline updates including FDA and EC approvals for several partnered therapies.

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.